We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$2.11B
AUM Growth
-$8.65M
Cap. Flow
+$15M
Cap. Flow %
0.71%
Top 10 Hldgs %
31.28%
Holding
1,253
New
97
Increased
492
Reduced
474
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 8.45%
3 Financials 7.51%
4 Healthcare 6.74%
5 Communication Services 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFN
1101
PIMCO Income Strategy Fund II
PFN
$693M
$140K 0.01%
13,819
-1,846
-12% -$20K
SVC
1102
Service Properties Trust
SVC
$1.08B
$140K 0.01%
2,500
-235
-9% -$13.4K
EGAN icon
1103
eGain
EGAN
$187M
$139K 0.01%
13,600
+1,200
+10% +$13.6K
EZPW icon
1104
Ezcorp Inc
EZPW
$1.87B
$136K 0.01%
17,934
TACO
1105
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$136K 0.01%
+15,610
New +$138K
GGT
1106
Gabelli Multimedia Trust
GGT
$169M
$134K 0.01%
14,872
OBSV
1107
DELISTED
ObsEva SA Ordinary Shares
OBSV
$134K 0.01%
43,145
-1,200
-3% -$3.4K
MFD
1108
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$133K 0.01%
14,006
+1,040
+8% +$10.2K
NCV
1109
Virtus Convertible & Income Fund
NCV
$375M
$130K 0.01%
5,446
-3,875
-42% -$94.2K
BRW
1110
Saba Capital Income & Opportunities Fund
BRW
$336M
$127K 0.01%
+14,006
New +$129K
GALT icon
1111
Galectin Therapeutics
GALT
$223M
$120K 0.01%
30,998
+13,000
+72% +$44.1K
MRKR icon
1112
Marker Therapeutics
MRKR
$20.3M
$118K 0.01%
7,007
SRNE
1113
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$118K 0.01%
15,500
+3,500
+29% +$29.7K
NNDM
1114
Nano Dimension
NNDM
$312M
$116K 0.01%
20,634
+1,000
+5% +$6.29K
RVSB icon
1115
Riverview Bancorp
RVSB
$108M
$116K 0.01%
16,000
SWN
1116
DELISTED
Southwestern Energy Company
SWN
$116K 0.01%
21,000
+250
+1% +$1.22K
VVR icon
1117
Invesco Senior Income Trust
VVR
$456M
$115K 0.01%
25,801
HIL
1118
DELISTED
Hill International, Inc. Common Stock
HIL
$114K 0.01%
+54,865
New +$128K
CLVS
1119
DELISTED
Clovis Oncology, Inc.
CLVS
$113K 0.01%
25,350
+1,800
+8% +$8.67K
NIM icon
1120
Nuveen Select Maturities Municipal Fund
NIM
$117M
$112K 0.01%
+10,358
New +$113K
BBVA icon
1121
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
$110K 0.01%
16,662
-1,616
-9% -$10.4K
CLMT icon
1122
Calumet Specialty Products
CLMT
$3.6B
$109K 0.01%
13,802
-6,800
-33% -$46.8K
PAA icon
1123
Plains All American Pipeline
PAA
$17.1B
$104K ﹤0.01%
10,253
-142
-1% -$1.41K
VKTX icon
1124
Viking Therapeutics
VKTX
$4.05B
$104K ﹤0.01%
+16,500
New +$102K
BRMK
1125
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$104K ﹤0.01%
10,500

Similar funds

Wedbush Securities's Q3 2021 Portfolio in Review

As of Q3 2021, Wedbush Securities held 1,253 positions worth $2.11B, down 0.41% from $2.12B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Wedbush Securities's Q3 2021 filing shows 97 new, 492 increased, 474 reduced and 86 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF July: 19,597 shares worth $679K. The largest sale was iShares ESG Aware US Aggregate Bond ETF, an estimated $9.99M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Wedbush Securities's largest Q3 2021 buy was FT Vest US Equity Buffer ETF July: 19,597 shares worth $679K.
  • Wedbush Securities added most to Vanguard Total Bond Market in Q3 2021, an estimated $10.3M increase.
  • Wedbush Securities's biggest Q3 2021 reduction was Microsoft, cutting an estimated $2.95M.
  • Wedbush Securities fully exited iShares ESG Aware US Aggregate Bond ETF in Q3 2021, selling an estimated $9.99M.
  • Wedbush Securities's ten largest holdings make up 31% of its $2.11B portfolio in Q3 2021.
  • Wedbush Securities opened 97 new positions and closed 86 in Q3 2021.
  • Wedbush Securities's portfolio value fell 0.41% quarter-over-quarter to $2.11B.

Based on Wedbush Securities's 13F filing for Q3 2021, filed 8 Oct 2021.